According to the MHRA-approved Summary of Product Characteristics (SmPC), the most commonly reported adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation, abdominal pain, and reduced appetite
HDACs are involved in a wide range of biological processes, including cell growth, differentiation, apoptosis, and metabolism
tirzepatide can do the same through its GLP-1 effects, albeit through a different neurochemical pathway
Spironolactone is usually taken daily, while semaglutide is a once-weekly injection
lean muscle mass loss may also be of greater clinical significance People with cardiovascular disease or arrhythmias : The observed increase in resting heart rate with GLP-1 and glucagon receptor agonism warrants careful monitoring in those with established heart disease or rhythm disorders People with pre-existing diabetic retinopathy : Rapid improvement in HbA1c may be associated with early worsening of retinopathy
Prefilled syringes from compounding pharmacies versus doing it yourself Not all prefilled syringes are created equal